Victoria Monge-Fuentes, Claudia Arenas, Priscilla Galante, Jacqueline Coimbra Gonçalves, Márcia Renata Mortari, Elisabeth Ferroni Schwartz
Index: 10.1016/j.pharmthera.2018.03.007
Full Text: HTML
The complex process of pain control commonly involves the use of systemic analgesics; however, in many cases, a more potent and effective polypharmacological approach is needed to promote clinically significant improvement. Additionally, considering side effects caused by current painkillers, drug discovery is once more turning to nature as a source of more efficient therapeutic alternatives. In this context, arthropod venoms contain a vast array of bioactive substances that have evolved to selectively bind to specific pharmacological targets involved in the pain signaling pathway, playing an important role as pain activators or modulators, the latter serving as promising analgesic agents. The current review explores how the pain pathway works and surveys neuroactive compounds obtained from arthropods' toxins, which function as pain modulators through their interaction with specific ion channels and membrane receptors, emerging as promising candidates for drug design and development.
Double-barreled gun: Combination of PARP inhibitor with conv...
2018-04-03 [10.1016/j.pharmthera.2018.03.006] |
Extracellular vesicles as potential biomarkers for alcohol- ...
2018-04-03 [10.1016/j.pharmthera.2018.03.009] |
ROCK inhibition in models of neurodegeneration and its poten...
2018-04-03 [10.1016/j.pharmthera.2018.03.008] |
Targeting the replication stress response in cancer
2018-03-24 [10.1016/j.pharmthera.2018.03.005] |
Sirtuin activators and inhibitors: Promises, achievements, a...
2018-03-22 [10.1016/j.pharmthera.2018.03.004] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved